BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33495604)

  • 21. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
    Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
    Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
    Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I
    Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
    Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
    Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATR Is a Therapeutic Target in Synovial Sarcoma.
    Jones SE; Fleuren EDG; Frankum J; Konde A; Williamson CT; Krastev DB; Pemberton HN; Campbell J; Gulati A; Elliott R; Menon M; Selfe JL; Brough R; Pettitt SJ; Niedzwiedz W; van der Graaf WTA; Shipley J; Ashworth A; Lord CJ
    Cancer Res; 2017 Dec; 77(24):7014-7026. PubMed ID: 29038346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.
    Cai W; Sun Y; Wang W; Han C; Ouchida M; Xia W; Zhao X; Sun B
    Pathol Oncol Res; 2011 Jun; 17(2):357-67. PubMed ID: 21234732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
    Peng C; Guo W; Yang Y; Zhao H
    Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas.
    Jones KB; Su L; Jin H; Lenz C; Randall RL; Underhill TM; Nielsen TO; Sharma S; Capecchi MR
    Oncogene; 2013 May; 32(18):2365-71, 2375.e1-5. PubMed ID: 22797074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
    Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
    Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis and research progress of the synovial sarcoma of the nasal cavity and sinus].
    Zhou Z; Miao GY; Li YQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):571-574. PubMed ID: 29871316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
    Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
    Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
    Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
    Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
    Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JS; Kuntz KK; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
    PLoS One; 2016; 11(7):e0158888. PubMed ID: 27391784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor.
    Su L; Cheng H; Sampaio AV; Nielsen TO; Underhill TM
    Oncogene; 2010 Jul; 29(30):4352-61. PubMed ID: 20514024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Death by HDAC Inhibition in Synovial Sarcoma Cells.
    Laporte AN; Poulin NM; Barrott JJ; Wang XQ; Lorzadeh A; Vander Werff R; Jones KB; Underhill TM; Nielsen TO
    Mol Cancer Ther; 2017 Dec; 16(12):2656-2667. PubMed ID: 28878027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
    Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.